Your browser doesn't support javascript.
Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in South Korea: a nationwide cross-sectional survey.
Noh, Yunha; Kim, Ju Hwan; Yoon, Dongwon; Choe, Young June; Choe, Seung-Ah; Jung, Jaehun; Lee, Sang-Won; Shin, Ju-Young.
  • Noh Y; Sungkyunkwan University, Suwon, Gyeong gi-do, Korea.
  • Kim JH; Sungkyunkwan University, Suwon, Gyeong gi-do, Korea.
  • Yoon D; Sungkyunkwan University, Suwon, Gyeong gi-do, Korea.
  • Choe YJ; Korea University Anam Hospital, Seoul, Korea.
  • Choe SA; Korea University College of Medicine, Seoul, Korea.
  • Jung J; Gachon University College of Medicine, Incheon, Korea.
  • Lee SW; Sungkyunkwan University, Suwon, Gyeong gi-do, Korea.
  • Shin JY; Sungkyunkwan University, Suwon, Gyeong gi-do, Korea.
Epidemiol Health ; : e2022061, 2022 Jul 22.
Article in English | MEDLINE | ID: covidwho-2274367
ABSTRACT

Objectives:

To explore predictors of COVID-19 booster hesitancy among fully vaccinated young adults and parental factors on COVID-19 vaccine hesitancy for their children.

Methods:

A cross-sectional study was conducted via an online survey from December 2 to 20, 2021. We enrolled participants aged 18-49 years and elapsed ≥2 weeks after completing a primary series of COVID-19 vaccination. We estimated odds ratios (ORs) with 95% confidence intervals (CIs) using multivariate logistic regressions to evaluate factors associated with booster/vaccine hesitancy.

Results:

Among 2,993 participants, 48.8% indicated hesitancy (wait and see 40.2%; definitely not 8.7%). The booster hesitancy was more in females (OR 1.25, 95% CI 1.05-1.50), younger age group (1.44 [1.17-1.77] at 18-29 years vs. 40-49 years), lower education level (2.05 [1.10-3.82] in no high school vs. graduate degree), mRNA-1273 (2.01, 1.65-2.45 vs. BNT162b2), and those with serious adverse events following previous COVID-19 vaccination (2.03, 1.47-2.80). The main reasons for booster hesitancy were concerns about its safety (54.1%), followed by doubt about the efficacy (29.8%). Among 1,020 respondents who had children aged <18 years, 65.8% indicated COVID-19 vaccine hesitancy for their children; the hesitancy for children was higher at the younger age, and lower at lower education level, ChAdOx1 (vs. BNT162b2), and those with history of COVID-19 infection.

Conclusion:

Concerns on the efficacy and safety of COVID-19 vaccines were the major barrier to booster hesitancy. The initial COVID-19 vaccine type, younger age, women, lower education level, and adverse events following COVID-19 vaccine were the key predictors of booster hesitancy.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Epidemiol Health Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Epidemiol Health Year: 2022 Document Type: Article